Sign In
Get Clay Free →

Suggestions

    Michael Cima

    Professor at MIT and Associate Dean of Engineering

    Professional Background

    Dr. Michael J. Cima is a distinguished Professor of Materials Science and Engineering at the Massachusetts Institute of Technology (MIT), where he holds the prestigious David H. Koch Chair of Engineering. With a remarkable career in academia and industry, Prof. Cima has made significant contributions to both fields, especially recognized for his expertise in materials processing and engineering systems. In addition to his teaching responsibilities, he holds an appointment at the David H. Koch Institute for Integrative Cancer Research, underscoring his commitment to improving human health through innovative research.

    Prof. Cima has been a member of the National Academy of Engineering since 2011, an honor that signifies his profound impact on engineering and technology. As the faculty director of the Lemelson-MIT Program since 2009, he has been instrumental in inspiring a new generation of inventors and entrepreneurs, targeting young minds across the nation with a program designed to foster creativity and innovation in science and engineering.

    Education and Achievements

    Dr. Cima earned his PhD in Chemical Engineering from the prestigious University of California, Berkeley, establishing a strong foundation for his future contributions to the field. Over his prolific academic career, he has authored or co-authored over two hundred peer-reviewed scientific publications, evidencing his active engagement in research and contribution to scientific literature. Additionally, he holds over forty US patents, underscoring his innovative work in materials science and technology.

    Prof. Cima’s entrepreneurial spirit shines through his impressive track record in the startup ecosystem, where he has co-founded several successful companies. Notably, he is a co-founder of MicroChips Inc., a pioneering developer of microelectronic-based drug delivery and diagnostic systems. His insight and guidance were further showcased during his role as a senior consultant and management team member at Transform Pharmaceuticals Inc., a company that he played a critical role in starting, which was ultimately acquired by Johnson & Johnson Corporation.

    His leadership extends to several other ventures, where he has served as director at T2 Biosystems, a medical diagnostics company, and Taris Biomedical, a company dedicated to developing products for urological health. Prof. Cima also co-founded SpringLeaf Therapeutics, a specialty pharmaceutical company focused on innovating treatment solutions in health care.

    Notable Contributions

    One of Dr. Cima's groundbreaking achievements includes his role as a co-inventor of MIT’s renowned three-dimensional printing process, contributing to transformative changes in manufacturing and healthcare applications. His work has facilitated advancements in high-throughput systems for discovering novel crystal forms and formulations of pharmaceuticals, significantly impacting drug development processes.

    Additional accolades in his career include serving as Associate Dean of Engineering and co-director of the MIT Innovation Initiative, where he fosters a culture of innovation that empowers students and faculty alike. His engagements in various consulting roles further highlight his versatility and expertise in bridging academic advancement with industrial application, enhancing the efficacy of pharmaceutical development and diagnosis technology.

    Prof. Cima’s unwavering dedication to human health and his commitment to education have made him a respected figure in the domains of engineering, materials science, and entrepreneurship. His contributions help shape the future of medical technologies while inspiring future innovators to achieve excellence in science and engineering.

    Achievements

    • Elected to the National Academy of Engineering in 2011.
    • Holds the David H. Koch Chair of Engineering at MIT.
    • Author or co-author of over 200 peer-reviewed scientific papers.
    • Holder of over 40 US patents in materials processing and technology.
    • Co-inventor of MIT's three-dimensional printing process.
    • Co-founder of multiple successful startups, including MicroChips Inc., T2 Biosystems, Taris Biomedical, and SpringLeaf Therapeutics.
    • Served as faculty director of the Lemelson-MIT Program since 2009.
    • Former senior consultant and management team member at Transform Pharmaceuticals Inc., leading to its acquisition by Johnson & Johnson.

    tags=[

    Highlights

    Sep 6 · MIT News
    MIT researchers win grants to develop and test 14 innovative ideas ... - MIT News
    MIT researchers win grants to develop and test 14 innovative ideas ... - MIT News
    Daniel Hastings and Maria Yang appointed associate deans of engineering - India Education Diary
    Michael Cima
    Add to my network

    Location

    Greater Boston Area